Bovine Pericardium Scaffold as a Critical Tool for Cardiac Surgery with Mesenchymal Stem Cell Seeding : A Narrative Review
Main Article Content
Abstract
This review explores the significance of pericardial dissection in cardiac surgery for managing congenital heart disease (CHD). The procedure often results in intrapericardial adhesion formation, impacting outcomes and increasing hospitalization costs. The focus is on the bovine pericardium (BP) scaffold and its compatibility with mesenchymal stem cells (MSCs) seeding. Various pericardial substitutes have been utilized to achieve complete closure without inducing rapid cardiac constriction. Successful substitutes must prevent adhesions between the chest wall/lung and pericardium, minimizing the risk of injury during resternotomy. The review emphasizes the promising application of BP scaffolds, particularly when seeded with MSCs, facilitating differentiation into mesothelial cells. Different methodologies are discussed for optimal MSCs seeding in BP scaffolds, suggesting a positive outlook for expanding the use of bovine pericardium in cardiac surgery. The review highlights the extensive use of bovine pericardium as a xenograft in vascular applications, supported by theoretical evidence, with potential for further enhancement through MSC seeding, indicating promising prospects for tissue engineering and regenerative medicine advancements.
Downloads
Article Details
References
Melly L, Torregrossa G, Lee T, Jansens JL, Puskas JD. Fifty years of coronary artery bypass grafting. J Thorac Dis. 2018 Mar;10(3):1960–7. DOI: 10.21037/jtd.2018.02.43
Ishihara T, Ferrans VJ, Jones M, Boyce SW, Kawanami O, Roberts WC. Histologic and ultrastructural features of normal human parietal pericardium. Am J Cardiol. 1980 Nov;46(5):744–53. DOI: 10.1016/0002-9149(80)90424-5
Liu ZZ, Wong ML, Griffiths LG. Effect of bovine pericardial extracellular matrix scaffold niche on seeded human mesenchymal stem cell function. Sci Rep. 2016 Nov 15;6(1):37089. DOI: 10.1038/srep37089
Rosenbaum AJ, Grande DA, Dines JS. The use of mesenchymal stem cells in tissue engineering. Organogenesis. 2008 Jan 27;4(1):23–7. DOI: 10.4161/org.6048
Kuschel TJ, Gruszka A, Hermanns-Sachweh B, Elyakoubi J, Sachweh JS, Vázquez-Jiménez JF, et al. Prevention of Postoperative Pericardial Adhesions With TachoSil. Ann Thorac Surg. 2013 Jan;95(1):183–8. DOI: 10.1016/j.athoracsur.2012.08.057
Ionescu MI, Tandon AP, Mary DA, Abid A. Heart valve replacement with the Ionescu-Shiley pericardial xenograft. J Thorac Cardiovasc Surg. 1977 Jan;73(1):31–42. Avalaible at: https://pubmed.ncbi.nlm.nih.gov/831009/
Heydorn WH, Ferraris VA, Berry WR. Pericardial Substitutes: A Survey. Ann Thorac Surg. 1988 Nov;46(5):567–9. DOI: 10.1016/s0003-4975(10)64699-1
Neethling WML, Strange G, Firth L, Smit FE. Evaluation of a tissue-engineered bovine pericardial patch in paediatric patients with congenital cardiac anomalies: initial experience with the ADAPT-treated CardioCel(R) patch. Interact Cardiovasc Thorac Surg. 2013 Oct 1;17(4):698–702. DOI: 10.1093/icvts/ivt268
Boyd WD, Tyberg J V, Cox JL. A review of the current status of pericardial closure following cardiac surgery. Expert Rev Cardiovasc Ther. 2012 Sep 10;10(9):1109–18. DOI: 10.1586/erc.12.87
Kargar F, Aazami MH. Rotational pericardial flap: An alternative tension-free technique for pericardial closure. J Thorac Cardiovasc Surg. 2007 Aug;134(2):510–1. DOI: 10.1016/j.jtcvs.2007.04.006
Milgalter E, Uretzky G, Siberman S, Appelbaum Y, Shimon D V, Kopolovic J, et al. Pericardial meshing: an effective method for prevention of pericardial adhesions and epicardial reaction after cardiac operations. J Thorac Cardiovasc Surg. 1985 Aug;90(2):281–6. Avalaible at: https://pubmed.ncbi.nlm.nih.gov/4021529/
Ghorpade N, Hill D, Mohajeri M. Alternative for Primary Pericardial Closure: Sentry for Re-entry. Heart Lung Circ. 2004 Mar;13(1):52–5. DOI: 10.1016/j.hlc.2004.01.008
Rego A, Boyd WD, Gongora E, Johnson IWE, Munfakh NA, Pirris J, et al. Expert Opinions on the Debate of Pericardial Reconstruction in Cardiovascular Surgery: To Close or Not to Close? Heart Surg Forum. 2022 Jan 13;25(1):E008-E019. DOI: 10.1532/hsf.3943
Tamesue K, Hara K, Hara F, Nakajima T. Pericardial reconstruction using a pedicle flap of the diaphragmatic central tendon. The Japanese Journal of Thoracic and Cardiovascular Surgery. 2005 Sep 1;53(9):494–7. DOI: 10.1007/s11748-005-0094-7
Cissell DD, Hu JC, Griffiths LG, Athanasiou KA. Antigen removal for the production of biomechanically functional, xenogeneic tissue grafts. J Biomech. 2014 Jun;47(9):1987–96. DOI: 10.1016/j.jbiomech.2013.10.041
Chen RF, Lai CP. Constrictive pericarditis associated with Marlex mesh. Two case reports. Tex Heart Inst J. 2001;28(1):63–4. Avalaible at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC101135/
Sakuma K, Iguchi A, Ikada Y, Tabayashi K. Closure of the Pericardium Using Synthetic Bioabsorbable Polymers. Ann Thorac Surg. 2005 Nov;80(5):1835–40. DOI: 10.1016/j.athoracsur.2005.04.078
Rego A, Cheung PC, Harris WJ, Brady KM, Newman J, Still R. Pericardial closure with extracellular matrix scaffold following cardiac surgery associated with a reduction of postoperative complications and 30-day hospital readmissions. J Cardiothorac Surg. 2019 Dec 15;14(1):61. DOI: 10.1186/s13019-019-0871-5
Lutz B, Reeps C, Biro G, Knappich C, Zimmermann A, Eckstein HH. Bovine Pericardium as New Technical Option for In Situ Reconstruction of Aortic Graft Infection. Ann Vasc Surg. 2017 May;41:118–26. DOI: 10.1016/j.avsg.2016.07.098
Li X, Guo Y, Ziegler KR, Model LS, Eghbalieh SDD, Brenes RA, et al. Current Usage and Future Directions for the Bovine Pericardial Patch. Ann Vasc Surg. 2011 May;25(4):561–8. DOI: 10.1016/j.avsg.2010.11.007
Obermiller JF, Hodde JP, McAlexander CS, Kokini K, Badylak SF. A comparison of suture retention strengths for three biomaterials. Med Sci Monit. 2004 Jan;10(1):PI1-5. Avalaible at: https://medscimonit.com/abstract/index/idArt/11558
Chang Y, Lai PH, Wei HJ, Lin WW, Chen CH, Hwang SM, et al. Tissue regeneration observed in a basic fibroblast growth factor–loaded porous acellular bovine pericardium populated with mesenchymal stem cells. J Thorac Cardiovasc Surg. 2007 Jul;134(1):65-73.e4. DOI: 10.1016/j.jtcvs.2007.02.019
Stelly M, Stelly TC. Histology of CorMatrix Bioscaffold 5 Years After Pericardial Closure. Ann Thorac Surg. 2013 Nov;96(5):e127–9. DOI: 10.1016/j.athoracsur.2013.06.114
Olsen SB, Mcquinn WC, Feliciano P. Results of Carotid Endarterectomy Using Bovine Pericardium Patch Closure, with a Review of Pertinent Literature. Am Surg. 2016 Mar;82(3):221–6. Avalaible at: https://pubmed.ncbi.nlm.nih.gov/27099058/
Texakalidis P, Giannopoulos S, Charisis N, Giannopoulos S, Karasavvidis T, Koullias G, et al. A meta-analysis of randomized trials comparing bovine pericardium and other patch materials for carotid endarterectomy. J Vasc Surg. 2018 Oct;68(4):1241-1256.e1. DOI: 10.1016/j.jvs.2018.07.023
Biasi GM, Sternjakob S, Mingazzini PM, Ferrari SA. Nine-year experience of bovine pericardium patch angioplasty during carotid endarterectomy. J Vasc Surg. 2002 Aug;36(2):271–7. DOI: 10.1067/mva.2002.123685
Dalgliesh AJ, Parvizi M, Lopera-Higuita M, Shklover J, Griffiths LG. Graft-specific immune tolerance is determined by residual antigenicity of xenogeneic extracellular matrix scaffolds. Acta Biomater. 2018 Oct;79:253–64. DOI: 10.1016/j.actbio.2018.08.016
Boyd WD, Johnson WE, Sultan PK, Deering TF, Matheny RG. Pericardial Reconstruction Using an Extracellular Matrix Implant Correlates with Reduced Risk of Postoperative Atrial Fibrillation in Coronary Artery Bypass Surgery Patients. Heart Surg Forum. 2010 Oct 1;13(5):E311–6. DOI: 10.1532/HSF98.20091184
Lahtinen J, Satta J, Pokela R, Nissinen J, Juvonen T. Pericardial closure with polytetrafluoroethylene surgical membrane or biodegradable polyglycolic acid mesh after coronary artery bypass surgery--a baseline report. Ann Chir Gynaecol. 1998;87(1):36–9. Avalaible at: https://pubmed.ncbi.nlm.nih.gov/9598228/
Minale C, Hollweg G, Nikol S, Mittermayer Ch, Messmer B. Closure of the Pericardium Using Expanded Polytetrafluoroethylene GORE-TEX®-Surgical Membrane: Clinical Experience. Thorac Cardiovasc Surg. 1987 Oct 19;35(05):312–5. DOI: 10.1055/s-2007-1020253
Ozeren M. Consequences of PTFE membrane used for prevention of re-entry injuries in rheumatic valve disease. Cardiovascular Surgery. 2002 Oct;10(5):489–93. DOI: 10.1016/s0967-2109(02)00061-3
Kirshbom PM, Myung RJ, Simsic JM, Kramer ZB, Leong T, Kogon BE, et al. One Thousand Repeat Sternotomies for Congenital Cardiac Surgery: Risk Factors for Reentry Injury. Ann Thorac Surg. 2009 Jul;88(1):158–61. DOI: 10.1016/j.athoracsur.2009.03.082
Mills SA. Complications associated with the use of heterologous bovine pericardium for pericardial closure. J Thorac Cardiovasc Surg. 1986 Sep;92(3 Pt 1):446–9. Avalaible at: https://pubmed.ncbi.nlm.nih.gov/3489138/
Khorramirouz R, Go JL, Noble C, Morse D, Lerman A, Young MD. In Vivo Response of Acellular Porcine Pericardial for Tissue Engineered Transcatheter Aortic Valves. Sci Rep. 2019 Jan 31;9(1):1094. DOI: 10.1038/s41598-018-37550-2
Nair V, Law KB, Li AY, Phillips KRB, David TE, Butany J. Characterizing the inflammatory reaction in explanted Medtronic Freestyle stentless porcine aortic bioprosthesis over a 6-year period. Cardiovascular Pathology. 2012 May;21(3):158–68. DOI: 10.1016/j.carpath.2011.05.003
Elassal AA, AL-Radi OO, Zaher ZF, Dohain AM, Abdelmohsen GA, Mohamed RS, et al. Equine pericardium: a versatile alternative reconstructive material in congenital cardiac surgery. J Cardiothorac Surg. 2021 Dec 23;16(1):110. DOI: 10.1186/s13019-021-01494-y
Griffiths LG, Choe LH, Reardon KF, Dow SW, Christopher Orton E. Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials. 2008 Sep;29(26):3514–20. DOI: 10.1016/j.biomaterials.2008.05.006
Zeiger E, Gollapudi B, Spencer P. Genetic toxicity and carcinogenicity studies of glutaraldehyde?a review. Mutation Research/Reviews in Mutation Research. 2005 Mar;589(2):136–51. DOI: 10.1016/j.mrrev.2005.01.001
Williams DF, Bezuidenhout D, de Villiers J, Human P, Zilla P. Long-Term Stability and Biocompatibility of Pericardial Bioprosthetic Heart Valves. Front Cardiovasc Med. 2021 Sep 13;8. DOI: 10.3389/fcvm.2021.728577
Braga-Vilela AS, Pimentel ER, Marangoni S, Toyama MH, de Campos Vidal B. Extracellular Matrix of Porcine Pericardium: Biochemistry and Collagen Architecture. Journal of Membrane Biology. 2008 Jan 3;221(1):15–25. DOI: 10.1007/s00232-007-9081-5
Pok S, Jacot JG. Biomaterials Advances in Patches for Congenital Heart Defect Repair. J Cardiovasc Transl Res. 2011 Oct 7;4(5):646–54. DOI: 10.1007/s12265-011-9289-8
McMillan WD, Leville CD, Hile CN. Bovine pericardial patch repair in infected fields. J Vasc Surg. 2012 Jun;55(6):1712–5. DOI: 10.1016/j.jvs.2011.11.139